Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details) - Customer Concentration Risk	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Customer A | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage			19.10%
Customer B | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage	10.40%
Customer B | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage	17.80%		12.20%
Customer D | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage	10.00%
Customer D | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage	19.40%
Customer E | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage	17.80%
Genentech, Inc. and Roche Group | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage	42.10%	54.40%